Lung neuroendocrine tumors (LNETs) are uncommon cancers, and there is a paucity of
randomized evidence to guide practice. As a result, current guidelines from different …

Neuroendocrine tumors (NETs) are a diverse group of neoplasms arising from cells in the
diffuse neuroendocrine system. At least 17 different types of neuroendocrine cells are found …

This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the surgical management of pancreatic neuroendocrine tumors …

This manuscript is the result of the North American Neuroendocrine Tumor Society
consensus conference on the medical management and surveillance of metastatic and …

With the recent approval of 177Lu-DOTATATE for use in gastroenteropancreatic
neuroendocrine tumors, access to peptide receptor radionuclide therapy is increasing …

Gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) arise from neuroendocrine
cells found throughout the gastrointestinal tract and islet cells of the pancreas. The incidence …

Small bowel neuroendocrine tumors (NETs) are increasing in incidence and are now the
most common primary malignancies of the small intestine. Despite this increase, the vague …

Objectives To predict histopathologic growth patterns (HGPs) in colorectal liver metastases
(CRLMs) with a noninvasive radiomics model. Methods Patients with chemotherapy-naive …

Objectives To compare the diagnostic accuracy of dynamic contrast-enhanced phases,
hepatobiliary phase (HBP), and diffusion-weighted imaging (DWI) for the detection of liver …

Pancreatic neuroendocrine tumors (PNETs) arise from endocrine pancreatic cells and
comprise 3-5% of pancreatic cancers. Surgical resection is the only potentially curative …